Can the dose of diltiazem (Cardizem) 30 mg immediate‑release tablets every 6 hours be increased?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Diltiazem 30 mg Every 6 Hours Be Increased?

Yes, the dose of diltiazem immediate-release 30 mg every 6 hours (120 mg total daily) can and often should be increased, as this is below the typical therapeutic range for most indications.

Dosing Framework

Current Dose Assessment

Your patient is receiving 30 mg every 6 hours = 120 mg total daily dose. This is at the lower end of the therapeutic spectrum for diltiazem.

Guideline-Based Dosing Ranges

For oral immediate-release diltiazem 1, 2:

  • Initial dosing: 120 mg daily in divided doses
  • Maintenance range: 120-360 mg daily in divided or single doses with long-acting formulations
  • Maximum studied: Up to 480 mg daily

Standard immediate-release regimen 3:

  • Typical dosing: 30-90 mg four times daily (not every 6 hours, but QID)
  • This translates to 120-360 mg total daily

Titration Strategy

Increase the dose systematically 4:

  1. From 120 mg daily → 180-240 mg daily: This is a reasonable first step

    • Can achieve this by increasing to 45 mg every 6 hours OR 60 mg every 8 hours
    • Monitor for 7-14 days before further titration 4
  2. Maximum antihypertensive/antianginal effect: Usually observed by 14 days of chronic therapy 4

  3. Further titration if needed: Can increase up to 360 mg daily in divided doses

    • Some patients may require up to 480 mg daily 4
  4. Dose-response relationship: There is departure from linearity with increasing doses—the half-life increases slightly with higher doses, and side effects (particularly first-degree AV block, dizziness, and sinus bradycardia) increase proportionally 4

Critical Monitoring Parameters

Before increasing the dose, exclude contraindications 1:

  • AV block greater than first degree or SA node dysfunction (without pacemaker)
  • Decompensated systolic heart failure or severe LV dysfunction
  • Hypotension
  • WPW syndrome with atrial fibrillation/flutter
  • Hepatic or renal dysfunction (requires dose adjustment)

Monitor closely during titration 4:

  • Heart rate and blood pressure at rest
  • PR interval on ECG (watch for progressive AV block)
  • Signs of heart failure exacerbation
  • Liver function tests (diltiazem can rarely cause acute hepatic injury)

Common Pitfalls to Avoid

  1. Dosing frequency confusion: Immediate-release diltiazem is typically dosed three to four times daily, not strictly every 6 hours. The every-6-hour regimen (QID) is appropriate, but ensure adequate total daily dose.

  2. Premature titration: Wait 7-14 days between dose adjustments to assess full therapeutic effect 4

  3. Ignoring drug interactions: Diltiazem is a CYP3A4 substrate and moderate inhibitor 1. Monitor for interactions with:

    • Other AV nodal blocking agents (beta-blockers, digoxin)
    • Statins (particularly simvastatin)
    • Anticoagulants (increases digoxin levels, can affect warfarin INR)
  4. Not considering long-acting formulations: If the patient requires doses above 180-240 mg daily, strongly consider switching to extended-release formulations (once or twice daily dosing) for better compliance and more stable drug levels 4, 5

Practical Recommendation

Increase to 45-60 mg every 6-8 hours (180-240 mg total daily) as the next step, provided the patient has no contraindications. Reassess in 7-14 days for efficacy and tolerability. If inadequate response and no adverse effects, can titrate further toward 360 mg daily in divided doses.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.